Altered cerebral perfusion in children with Langerhans cell histiocytosis after chemotherapy

Michelle Han1, Lily H Kim1, Katie Shpanskaya1

  • 1Department of Pediatrics, Pediatric Hematology/Oncology, Stanford University School of Medicine, Stanford, California.

Pediatric Blood & Cancer
|December 6, 2019
PubMed

Insights

Children with Langerhans cell histiocytosis (LCH) show reduced cerebral blood flow (CBF) in specific brain areas. This finding may link LCH to neurological symptoms and chemotherapy effects.

Area of Science:

  • Pediatric Neurology
  • Neuroimaging
  • Medical Physics

Background:

  • Langerhans cell histiocytosis (LCH) can cause neurological symptoms in children.
  • Cerebral hemodynamic changes in pediatric LCH are not well understood.
  • Arterial spin-labeling (ASL) perfusion MRI offers a method to study these changes.

Purpose of the Study:

  • To investigate cerebral hemodynamic properties in children with LCH.
  • To utilize ASL perfusion MRI to assess cerebral blood flow (CBF).
  • To compare CBF in LCH patients (pre- and post-treatment) with healthy controls.

Main Methods:

  • Retrospective study of 23 children with biopsy-proven LCH.
  • ASL perfusion MRI data analyzed using region of interest (ROI) methodology.
  • CBF quantified in specific brain regions and compared between groups.

Main Results:

  • Reduced CBF observed in post-treatment LCH patients compared to controls in the angular gyrus, anterior prefrontal cortex, and dorsal anterior cingulate cortex.
  • Perfusion abnormalities were predominantly noted in the right cerebral hemisphere.
  • No significant CBF differences were found in the hippocampus or orbitofrontal cortex.

Conclusions:

  • Specific cerebral regions show consistently reduced perfusion in children with LCH.
  • These perfusion deficits may stem from LCH disease processes or chemotherapy side effects.
  • Integrating cognitive assessments with hemodynamic data can further elucidate LCH-associated neurotoxicity.
Abstract

Related Concept Videos